Home

John Vander Vort

CIK 1379218 · last filed 2019-07-18

John Vander Vort is a corporate insider who has filed 12 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing, for PETX, was dated Jul 18, 2019. Across all open-market trades the lifetime net is −$44.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $70.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$70.43M

Companies

2

Total Filings

12

Lifetime Open-Market Net

-$44.06M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARATANA THERAPEUTICS, INC. (PETX) Delisted Director 3,625,419 — — $2.88M 8 2019-07-18
PCRX 10%+ Owner 2,790,479 $25.24 $70.43M -$46.94M 3 2013-03-13

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-07-18 ARATANA THERAPEUTICS, INC. (PETX) Delisted Disp (D) −43,000 $0 EDGAR
2019-06-07 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) +4,500 $0 EDGAR
2018-07-30 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) +4,500 $0 EDGAR
2017-06-23 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) +4,500 $0 EDGAR
2016-06-28 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) +4,500 $0 EDGAR
2015-06-19 ARATANA THERAPEUTICS, INC. (PETX) Delisted Grant (A) — $0 EDGAR
2015-03-06 ARATANA THERAPEUTICS, INC. (PETX) Delisted Sell (S) −6,137 -$122.8K EDGAR
2013-07-02 ARATANA THERAPEUTICS, INC. (PETX) Delisted Mixed +3,934,616 $3.00M EDGAR
2013-03-13 PCRX Sell (S) −4,000,000 -$111.44M EDGAR
2011-11-22 PCRX Buy (P) +4,153,842 $27.00M EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.